Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALIMESO: Pemetrexed, Cisplatin, and Vitamin B12 in Unresectable Pleural Mesothelioma
NCT00541073Phase 2Completed
- Sponsor
- Centre Oscar Lambret
- Start
- Jun 2007
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemetrexed in pleural mesothelioma, sponsored by Centre Oscar Lambret. Primary endpoint: Individual dosage-adapted protocol. Started Jun 2007; status: completed.
02
Drugs
pemetrexed
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on NCT00541073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541073.